ANUH PHARMA
Back to Cashflow Statement
|
ANUH PHARMA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.57 Cr | ₹-12 Cr | ₹-19 Cr | ₹-33 Cr | ₹22 Cr |
What is the latest Cash Flow from Financing Activities ratio of ANUH PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.57 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-19 Cr |
Mar2021 | ₹-33 Cr |
Mar2020 | ₹22 Cr |
How is Cash Flow from Financing Activities of ANUH PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.57 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-19 Cr | Negative | |
Mar2021 | ₹-33 Cr | Negative | |
Mar2020 | ₹22 Cr | - |
Compare Cash Flow from Financing Activities of peers of ANUH PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ANUH PHARMA | ₹1,077.2 Cr | 2.8% | -1.3% | -3.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | -0.2% | -0.5% | 10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,867.0 Cr | 4% | 4.8% | 50.5% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.4% | 3.1% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 5.9% | 9.1% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4.8% | 2.2% | 2.9% | Stock Analytics |
ANUH PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ANUH PHARMA | 2.8% |
-1.3% |
-3.5% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses